Phase 2 Myocardial Injury Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
Stratified Medicine of Eplerenone in Acute Myocardial Infarction or Injury and no Obstructive Coronary Arteries.
Myocardial InjuryMyocardial Infarction, AcuteMyocardial Infarction With Nonobstructive Coronary Arteries
NHS National Waiting Times Centre Board400 enrolled2 locationsNCT05198791
Recruiting
Phase 2
NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial
Myocardial InjuryAcute Kidney InjuryIschemia Reperfusion Injury
Kaiser Permanente304 enrolled1 locationNCT04750616
Recruiting
Phase 2
Study to Assess Safety and Efficacy of Treating Symptomatic, Ischemic, Chronic Congestive Heart Failure Patients with an LVEF of ≤40% with Fresh, Uncultured, Autologous, Adipose-derived Regenerative Cells Isolated from Lipoaspirate.
Heart FailureMyocardial InjuryCoronary Artery Disease+1 more
Ralf Rothoerl36 enrolled1 locationNCT06705023
Active
Phase 2
Chronic Myocardial Injury-Evaluating The Possible Role Of Sodium Glucose Co-Transporter 2 Inhibition (CHIRON)
Chronic Myocardial Injury
Flinders University of South Australia50 enrolled5 locationsACTRN12620001256965